Aberrant DNA methylation in Ewing sarcoma.
|
Fred Hutchinson Cancer Research Center / Scott Borinstein |
Young Investigator Grants |
2009 |
Washington |
A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor |
Dana-Farber Cancer Institute / Shuning He, PhD |
Young Investigator Grants |
2015 |
Massachusetts |
A Role for Notch in Self-renewal in Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Myron Ignatius, PhD |
'A' Award Grants |
2012 |
Massachusetts |
A Role for Non-canonical Wnt/PCP Signaling in Growth and Self-Renewal of Embryonal Rhabdomyosarcoma |
Massachusetts General Hospital / Madeline Hayes, PhD |
Young Investigator Grants |
2016 |
Massachusetts |
A Pilot Study of the Feasibility and Acceptability of an Interactive Computerized Symptom Assessment Tool to Assess Disease and Treatment-Related Symptoms Experienced by Children with Cancer |
University of California San Francisco / Tina Baggott, RN, PhD, PNP |
Nurse Researcher Grants |
2009 |
California |
A Nurse-Led Structured Discharge Teaching Intervention for Parents of Newly Diagnosed Pediatric Oncology Patients |
University of Alabama at Birmingham / Wendy Landier, RN/PhD |
Nurse Researcher Grants |
2016 |
Alabama |
A Novel Target for Neuroblastoma Treatment |
Beckman Research Institute of City of Hope / Linda Malkas, Ph.D. |
Reach Grants |
2014 |
California |
A novel mouse model of rhabdomyosarcoma |
Vanderbilt University Medical Center / Chin Chiang, PhD |
Innovation Grants |
2012 |
Tennessee |
A novel compound for treatment of T cell leukemia |
Huntsman Cancer Institute / Nikolaus Trede |
Innovation Grants |
2010 |
Utah |
A Novel Adjunctive LAT-Activating CART (ALA-CART) Cell Platform for the Treatment of Acute Leukemia |
University of Colorado Denver_ Anschutz Medical Campus / Catherine Danis, PhD |
Young Investigator Grants |
2023 |
Colorado |